Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TGTX
TGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TGTX News
ACT Capital Management Acquires New Position in Alumis Worth $4.36 Million
21h ago
Yahoo Finance
S&P 500 and Nasdaq Reach New Highs on Iran Deal Hopes
4d ago
Yahoo Finance
TGTX Q1 2025 Earnings Call Transcript
4d ago
NASDAQ.COM
TG Therapeutics (TGTX) Q1 2026 Earnings Transcript
4d ago
NASDAQ.COM
TG Therapeutics Q1 2026 Earnings Call Highlights
4d ago
seekingalpha
TG Therapeutics Raises 2026 Revenue Outlook to $925 Million
4d ago
stocktwits
TG Therapeutics Q1 Earnings Beat Expectations with Strong Revenue Growth
4d ago
seekingalpha
TG Therapeutics Set to Announce Q1 Earnings with Strong Revenue Growth
5d ago
seekingalpha
TG Therapeutics to Host Q1 2026 Earnings Call on May 6
Apr 30 2026
Newsfilter
TG Therapeutics Presents New Data on BRIUMVI at AAN 2026
Apr 22 2026
Newsfilter
TG Therapeutics Completes Enrollment in Phase 3 Trial for BRIUMVI
Apr 16 2026
NASDAQ.COM
TG Therapeutics Completes Enrollment in Phase 3 BRIUMVI Trial
Apr 15 2026
Newsfilter
Analysis of XBI ETF Trading Dynamics
Apr 07 2026
NASDAQ.COM
Analysis of XBI ETF's 52-Week Price Fluctuations
Mar 30 2026
NASDAQ.COM
TG Therapeutics Secures $750 Million Credit Facility
Mar 19 2026
NASDAQ.COM
TG Therapeutics Secures $750M Credit Facility
Mar 19 2026
seekingalpha
Show More News
